- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 318 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 324 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 04.12.25 | Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview | 1 | GlobeNewswire (USA) | ||
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 386 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 258 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 399 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 483 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 346 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 366 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 364 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen | |
| 10.09.25 | Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets | 298 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic... ► Artikel lesen | |
| 08.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division | 435 | ACCESS Newswire | Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. ORLANDO, FL / ACCESS Newswire / September 8, 2025... ► Artikel lesen | |
| 03.09.25 | Exousia Pro, Inc.: Exousia Pro Creates New Subdivisions | 430 | ACCESS Newswire | Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion... ► Artikel lesen | |
| 25.06.25 | Marijuana Inc.: Exousia Pro Files Reg A. | 281 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / June 25, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of... ► Artikel lesen | |
| 18.06.25 | Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board | 611 | ACCESS Newswire | Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company... ► Artikel lesen | |
| 30.04.25 | Marijuana Inc.: Exousia Pro Will Launch a Web Series with Our New Consultant | 320 | ACCESS Newswire | Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series. ORLANDO, FL / ACCESS Newswire / April 30, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage... ► Artikel lesen | |
| 29.04.25 | Marijuana Inc.: Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application | 342 | ACCESS Newswire | - Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based... ► Artikel lesen | |
| 21.04.25 | Marijuana Inc.: Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview | 413 | ACCESS Newswire | A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc.,... ► Artikel lesen | |
| 17.04.25 | Marijuana Inc.: Exousia Pro Offers Guidance on New Subdivisions | 404 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is... ► Artikel lesen | |
| 08.04.25 | Marijuana Inc.: Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show | 440 | ACCESS Newswire | Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 257,30 | -3,02 % | BARCLAYS stuft Sartorius Vorzuege auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Sartorius von 280 auf 300 Euro angehoben und die Einstufung auf "Overweight" belassen. Sartorius sei der klassenbeste... ► Artikel lesen | |
| SERVE ROBOTICS | 14,770 | -4,15 % | Why Serve Robotics Stock Popped Today | ||
| DRONESHIELD | 2,305 | +4,77 % | DroneShield: Technische Analyse und Kursentwicklung | ||
| UNUSUAL MACHINES | 14,200 | -5,71 % | Unusual Machines to Participate in the 28th Annual Needham Growth Conference | ORLANDO, FLORIDA / ACCESS Newswire / January 5, 2026 / Unusual Machines, Inc. (NYSE American:UMAC), a leading provider of NDAA-compliant drone components, will participate in the 28th Annual Needham... ► Artikel lesen | |
| KRATOS DEFENSE | 98,02 | +9,79 % | 2026: "Ich will die Zukunft" - 100 Prozent mit Kratos, Commerzbank und Bloom Energy | Kommentar: Ein toller Jahresstart bei unseren Depot-Titeln Infineon, Kratos, Bayer, Intel oder Lynas! Und die gerade in Las Vegas startende CES mit Nvidia, Siemens, Xiaomi macht Lust auf mehr. Starker... ► Artikel lesen | |
| COMPOSECURE | 22,180 | +3,79 % | CompoSecure, Inc. today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited ("Husky") | SOMERSET, N.J., Dec. 24, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NYSE: CMPO) today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection... ► Artikel lesen | |
| EVOLV TECHNOLOGIES | 7,170 | +0,49 % | Why Analysts Favor Evolv Technologies (EVLV) | ||
| PVA TEPLA | 25,320 | +2,76 % | AKTIE IM FOKUS: PVA Tepla mit Kurssprung nach Metzler-Kaufempfehlung | FRANKFURT (dpa-AFX) - Eine Kaufempfehlung durch das Bankhauses Metzler hat am Donnerstag der Erholung von PVA Tepla neuen Schub gegeben. Die Titel des Chipausrüsters zogen im frühen Handel um bis zu... ► Artikel lesen | |
| INNOVATIVE SOLUTIONS & SUPPORT | 18,330 | -2,40 % | IS&S Rebrands to Innovative Aerosystems | New brand identity reflects focus on integrating advanced avionics with intelligent system designs to deliver innovative aerospace solutions
EXTON, Pa.--(BUSINESS WIRE)--Innovative Solutions & Support... ► Artikel lesen | |
| HOENLE | 8,100 | +9,76 % | HOENLE AG - Stabilität als stiller Werttreiber | ||
| GEOSPACE TECHNOLOGIES | 21,990 | +8,33 % | GEOSPACE TECHNOLOGIES CORP - 10-K, Annual Report | ||
| ITURAN LOCATION AND CONTROL | 43,450 | +0,49 % | Dividendenbekanntmachungen (29.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 6,35 JPY 0,0344 EUR AGC INC JP3112000009 105 JPY 0,5701 EUR AMERICAN TOWER CORPORATION US03027X1000 1... ► Artikel lesen | |
| AGEAGLE AERIAL SYSTEMS | 1,695 | -2,31 % | EagleNXT completes spare parts delivery for UAE drone fleet | ||
| KLA | 1.202,80 | +5,75 % | ROUNDUP/Aktien New York: Dow auf Rekordhoch - Venezuela-Fantasie treibt Ölaktien | NEW YORK (dpa-AFX) - Am zweiten Handelstag des neuen Börsenjahres haben Investoren an den US-Aktienmärkten auf Ölwerte gesetzt. Am Montag im frühen Handel profitierten die Aktien der Öl- und Gasindustrie... ► Artikel lesen | |
| AXON ENTERPRISE | 544,80 | +3,53 % | Is Axon (AXON) Stock a Buy in 2026? |
Das Unternehmen EXOUSIA ADVANCED MATERIALS INC kann der Branche Sonstige Technologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.